Roark M
Owen Healthcare Inc., Houston.
Hospitals. 1993 Jan 20;67(2):56.
As the emergence of new drugs and technology and the growing acuity of patients drive up the cost of hospital pharmaceuticals, hospital administrators can act to slow the rate of increase. The key, writes the author, lies in recognizing that newness in pharmaceuticals does not equal clinical superiority or cost-effectiveness.
随着新药和新技术的出现以及患者病情的日益严重，医院药品成本不断攀升，医院管理人员可以采取行动减缓成本增长速度。作者写道，关键在于认识到药品的新颖性并不等同于临床优越性或成本效益。
